Complete weaning off immunosuppression in HCV liver transplant recipients is feasible and favourably impacts on the progression of disease recurrence
Open Access
- 30 April 2006
- journal article
- clinical trial
- Published by Elsevier BV in Journal of Hepatology
- Vol. 44 (4), 702-709
- https://doi.org/10.1016/j.jhep.2005.11.047
Abstract
No abstract availableThis publication has 36 references indexed in Scilit:
- Immunological tolerance and liver transplantationJournal of Hepatology, 2004
- Long-term benefit of interferon α therapy of chronic hepatitis D: regression of advanced hepatic fibrosisGastroenterology, 2004
- Long-term outcome of liver transplants for chronic hepatitis C: a 10-year follow-upTransplantation, 2004
- Quality of life in adult survivors beyond 10 years after liver, kidney, and heart transplantationTransplantation, 2003
- The role of immunosuppression in recurrence of hepatitis CLiver Transplantation, 2003
- Report of the First International Liver Transplantation Society Expert Panel Consensus Conference on liver transplantation and hepatitis CLiver Transplantation, 2003
- Host and donor risk factors before and after liver transplantation that impact HCV recurrenceLiver Transplantation, 2003
- Update of the International Banff Schema for liver allograft rejection: Working recommendations for the histopathologic staging and reporting of chronic rejectionHepatology, 2000
- Defining the outcome of immunosuppression withdrawal after liver transplantationHepatology, 1998
- Histological grading and staging of chronic hepatitisJournal of Hepatology, 1995